Author： Hochman Jerome H. Pudvah Nicole Qiu Julia Yamazaki Masayo Tang Cuyue Lin Jiunn H. Prueksaritanont Thomayant
Publisher： Springer Publishing Company
ISSN： 0724-8741
Source： Pharmaceutical Research, Vol.21, Iss.9, 2004-09, pp. : 1686-1691
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Risk Management of Simvastatin or Atorvastatin Interactions with CYP3A4 Inhibitors
By Molden Espen
Drug Safety, Vol. 31, Iss. 7, 2008-01 ,pp. :
Access to resources
Recommend
Atorvastatin/simvastatin/fusidic acid interaction: Rhabdomyolysis: 4 case reports
Reactions Weekly, Vol. 1, Iss. 1311, 2010-01 ,pp. :
Atorvastatin/fusidic acid/simvastatin interaction: Rhabdomyolysis: 4 case reports
Reactions Weekly, Vol. 1, Iss. 1336, 2011-01 ,pp. :
Risk factors for Rhabdomyolysis with Simvastatin and Atorvastatin
By Golomb Beatrice Evans Marcella
Drug Safety, Vol. 29, Iss. 12, 2006-01 ,pp. :
Risk Factors for Rhabdomyolysis with Simvastatin and Atorvastatin
Drug Safety, Vol. 29, Iss. 11, 2006-01 ,pp. :